ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,420Hybrid

Prostate Cancer and Prostatic Diseases

Acronym:pcan
•
Abbreviation (ISO):PROSTATE CANCER P D
•
Identifier (ISSN):1365-7852(Print)/1476-5608(Online)
•
Publisher:Springer Nature
Clarivate IF (2026)
6.9↑ +1.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Prostate Cancer and Prostatic Diseases

WoS Q1
24794.120184.620194.3120205.5520215.4620224.820235.120245.820256.92026
Annual Impact Factor Metric
Current (2026):6.9
Scopus SJR & RankScopus Q1
2.025
#1,420

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
85

85 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate13.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
135articles/year
34.08% Gold OA•78.69% Original Research

Aims & Scope

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.

Topics Covered (Recognized by AI)
Medicine99.6%Internal medicine96.4%Biology96.2%Genetics95.3%Cancer94.5%Prostate cancer90.8%Prostate74.2%Pathology56.6%Oncology49%Urology43.9%Surgery38.1%Chemistry37%Biochemistry34.5%Mathematics28.3%Radiology26.7%Endocrinology25.2%Statistics25%Prostatectomy20.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank55/333
IndexSCIE
JCRSCIE2026

UROLOGY & NEPHROLOGY

Q1
Rank13/134
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank49/333
IndexSCIE
JCISCIE2026

UROLOGY & NEPHROLOGY

Q1
Rank15/134
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.9
Articles / Year85
Total Citations58
2025
IF5.8
Articles / Year137
Total Citations453
2024
IF5.1
Articles / Year156
Total Citations1,654
2023
IF4.8
Articles / Year141
Total Citations2,313
2022
IF5.455
Articles / Year161
Total Citations2,720

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,420Scopus Q1SCImago Profile
Scopus Coverage:1997-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.025

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.18

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,702 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,851
3-Year Documents378
Citable Documents303

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate27.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
UrologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 13.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
1区ANDROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Prostate Cancer and Prostatic Diseases (acronym: pcan, abbr: PROSTATE CANCER P D, ISSN: 1365-7852) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in England since 1997. The periodical holds a Journal Impact Factor (JIF) of 6.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.025 (Q1), an H-index of 85.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 135 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,702 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
Quarterly
Founding Year
1997
Indexing & Databases
SCIEScopusPubMed
Editorial Address
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c6e85eb6-c37f-4d33-af1b-b51d000fc016
Database Updated: 2026-10-01